DONOR LEUKOCYTE INFUSIONS AS TREATMENT OF EPSTEIN-BARR-VIRUS LYMPHOPROLIFERATIVE DISORDERS (EBV-LPD) IN RECIPIENTS OF UNRELATED AND RELATED ALLOGENEIC TRANSPLANTS

被引:0
|
作者
PAPADOPOULOS, EB [1 ]
LADANYI, M [1 ]
机构
[1] MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A214 / A214
页数:1
相关论文
共 50 条
  • [11] Fatal outcome in a patient developing Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD) without measurable disease
    Ringhoffer, M
    Döhner, K
    Scheil, S
    Wilts, H
    Mertens, T
    Grimminger, W
    Döhner, H
    Bunjes, D
    BONE MARROW TRANSPLANTATION, 2001, 28 (06) : 615 - 618
  • [12] Unsuccessful CTL transfusion in a case of post-BMT Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD)
    Imashuku, S
    Goto, T
    Matsumura, T
    Naya, M
    Yamori, M
    Hojo, M
    Hibi, S
    Todo, S
    BONE MARROW TRANSPLANTATION, 1997, 20 (04) : 337 - 340
  • [13] EXPRESSION OF EPSTEIN-BARR-VIRUS (EBV) GENE-PRODUCTS AND RELATED CELLULAR PROTEINS IN POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLD)
    KAPLAN, MA
    HARRIS, NL
    LABORATORY INVESTIGATION, 1994, 70 (01) : A112 - A112
  • [14] EPSTEIN-BARR-VIRUS (EBV)-RELATED LYMPHOPROLIFERATIVE DISORDER WITH SUBSEQUENT EBV NEGATIVE T-CELL LYMPHOMA
    TAO, Q
    SRIVASTAVA, G
    LOKE, SL
    LIANG, RHS
    LIU, YT
    HO, FCS
    INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (01) : 33 - 39
  • [15] EPSTEIN-BARR-VIRUS SEROLOGY AND EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS
    SOKAL, EM
    CARAGIOZOGLOU, T
    LAMY, M
    REDING, R
    OTTE, JB
    TRANSPLANTATION, 1993, 56 (06) : 1394 - 1398
  • [16] PREVENTION AND TREATMENT OF EPSTEIN-BARR-VIRUS (EBV)-ASSOCIATED LYMPHOPROLIFERATIVE DISEASES IN IMMUNE DEFICIENT PATIENTS
    PURTILO, DT
    AIDS RESEARCH, 1986, 2 : S177 - S181
  • [17] Current results of donor leukocyte infusions (DLI) for treatment of Epstein-Barr virus-associated lymphoproliferative disorders (EBVLPD) following related and unrelated T cell depleted bone marrow transplant (TCDBMT).
    Papadopoulos, EB
    Small, T
    Ladanyi, M
    Boulad, F
    CastroMalaspina, H
    Childs, B
    Kernan, N
    Mackinnon, S
    Szabolcs, P
    Young, J
    OReilly, RJ
    BLOOD, 1996, 88 (10) : 2712 - 2712
  • [18] EPSTEIN-BARR-VIRUS - RELATED POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE OF DONOR ORIGIN IN 2 ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS
    IEMMOLO, RM
    GERUNDA, G
    MERENDA, R
    NERI, D
    POLETTI, A
    DANDREA, E
    CORNEO, B
    MONTAGNA, M
    MENIN, C
    DELMISTRO, A
    STRAZZABOSCO, M
    HEPATOLOGY, 1995, 22 (04) : 416 - 416
  • [19] Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients
    Haque, T
    Thomas, JA
    Falk, KI
    Parratt, R
    Hunt, BJ
    Yacoub, M
    Crawford, DH
    JOURNAL OF GENERAL VIROLOGY, 1996, 77 : 1169 - 1172
  • [20] THE EXPRESSION OF EPSTEIN-BARR-VIRUS LATENT PROTEINS IS RELATED TO THE PATHOLOGICAL FEATURES OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS
    DELECLUSE, HJ
    KREMMER, E
    ROUAULT, JP
    COUR, C
    BORNKAMM, G
    BERGER, F
    AMERICAN JOURNAL OF PATHOLOGY, 1995, 146 (05): : 1113 - 1120